#OP0249 #EULAR2022 Dr Machado presented pooled data >5000 pts. Poor #COVID outcomes in Pso, PsA and AxSpa were associated with the usual suspects: Age, male, high disease activity and comorbidities. No specific bDMARDs was associated. Good news for our patients @RheumNow https://t.co/itzmwqKCrH

Staggering facts by Prof Vital on #SLE and SkM Sx’s: - 50% of first Sx’s is SkM - SkM Sx are in top 3 concerns for pts - 34% pts w/SkM Sx stopped working median 4 yrs - SkM damage clusters with CVD damage #EULAR2022 @rheumnow https://t.co/NXEW3XYCQZ

📲The great debate on Telemedicine 💻 R. Landewe warns us against "check box medicine" and its consequences on AxSpA overdiagnosis. @RheumNow #EULAR2022 https://t.co/Xwg0aAdHwE

“#SLEDAI should be scored when there is joint swelling (not just tenderness)—note that only 48% of pts with tenderness will have u/s evidence of inflammation” – Prof E Vital #EULAR2022 @rheumnow https://t.co/hhsZ9wMAWs

JAK will quiet Still’s disease? 7 w Still’s 4 refractory disease had benefit w #JAKi POS0014. Needs more data but looks promising most w partial response . 5 on #Tofacitinib and 2 w #Baricitinib. ⁦@eular_org⁩ #EULAR2022 POS0014 ⁦@RheumNow⁩ https://t.co/j9IRgT9XJf

Insightful session with H Schulze-Koops: JAKi-Are all promises fulfilled? "JAKi have not shown us sufficient data to prove that they can induce remission or inhibit disease progression" @RheumNow #EULAR2022 https://t.co/SKKAS1ViIU

Dr. Werth shared her evidence based algorithm for managing cutaneous lupus published here: https://t.co/RytrxLdLHK #EULAR2022 @rheumnow https://t.co/wq28btM24U

#EULAR2022 @ChristianDejaco: Do we need see our patient at all? Provocative statement asking if some disease states can be evaluated, diagnosed, educated and monitored digitally. "It's already out there!" "Should we leave it to the market" or should rheum take a lead? @RheumNow https://t.co/iMrlKZgtbg

Pregnancy data in SpA from 122 pts 40% flared during pregnancy, more frequent 2nd trimester, pts w/ axial dz 7 pts required start of TNFi during 2nd or 3rd trimester 40% post-partum @RheumNow #EULAR2022 ABST#POST0151 https://t.co/cdFRhRuCVH